Juan Lucio Iovanna

38PUBLICATIONS
125CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsBiologically active moleculesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Jul 20, 2026
A comprehensive proteomic dataset of secretomes from primary pancreatic cancer cell cultures.

|May 18, 2026
Single-cell transcriptomic profiling of patient-derived pancreatic ductal adenocarcinoma primary cell cultures.

|Apr 23, 2026
Mapping National Definitions, Classifications, and Policy Approaches to Poor-Prognosis Cancers Across the G7 Cancer Initiative Countries.

|Dec 09, 2025
Adaptation of redox metabolism in drug-tolerant persister cells is a vulnerability to prevent relapse in pancreatic cancer.

Nadine Abdel Hadi, Gabriela Reyes-Castellanos, Tristan Gicquel

|Nov 17, 2025
Synergistic antitumor activity of sorafenib and the NUPR1 inhibitor LZX-2-73 in multiple cancer models.

Xi Liu, Matías Estaras, Emma Cosialls

Pageof 7

Frequent Collaborators

14 joint publications

Nelson Dusetti

9 joint publications

Ling Peng

5 joint publications

Patricia Santofimia-Castaño

5 joint publications

Gwen Lomberk